CE INFORMATION
Oncology Nursing Conference
Saturday, March 8, 2025 | Virtual Live CE Conference
Broadcast starts at 8:00 AM CT
HOW TO CLAIM CREDIT
In order to obtain your CE certificates, please follow the steps below at the conclusion of the event:
Enhancing Oncology Nursing Care in Advanced NSCLC:
Bridging Gaps in Rural and Underserved Communities
Provided by Talem Health and RME Collaborative:
ACKNOWLEDGEMENT
This initiative is co-supported by independent medical education grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.
CREDIT AVAILABLE
TARGET AUDIENCE
This activity is designed specifically for nurse practitioners, nurses, and other nursing professionals who provide cancer care to patients from rural and underserved communities.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be better able to:
FACULTY
Marianne J. Davies, DNP, ACNP, AOCNP, FAAN
Program Manager, Care Signature Oncology Service Line
Oncology Nurse Practitioner
Yale New Haven Hospital and Yale Comprehensive Cancer Center
Associate Professor
Yale University School of Nursing
New Haven, CT
Lance F. Ortega, MBA, BSN, RN, OCN
Executive Director, Clinical Operations
Texas Oncology
Dallas-Fort Worth, TX
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Pharmacotherapy credit for Advanced Practice Registered Nurses to be determined.
DISCLOSURE OF CONFLICTS OF INTEREST
Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
All relevant financial relationships have been mitigated.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Faculty
Marianne J. Davies, DNP, ACNP, AOCNP, FAAN, has no relevant financial relationships to disclose.
Lance F. Ortega, MBA, BSN, RN, OCN, has no relevant financial relationships to disclose.
Planners, Managers, and Reviewer
The Talem Health planners, managers, and reviewer have nothing to disclose.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Antibody-Drug Conjugates and Adverse Events: Improving Identification and Management
Among Oncology Nurses Serving Rural and Underserved Communities
Provided by Talem Health and RME Collaborative:
ACKNOWLEDGEMENT
This initiative is co-supported by independent medical education grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.
CREDIT AVAILABLE
TARGET AUDIENCE
This activity is designed specifically for nurse practitioners, nurses, and other nursing professionals who provide cancer care to patients from rural and underserved communities.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be better able to:
FACULTY
Marianne J. Davies, DNP, ACNP, AOCNP, FAAN
Program Manager, Care Signature Oncology Service Line
Oncology Nurse Practitioner
Yale New Haven Hospital and Yale Comprehensive Cancer Center
Associate Professor
Yale University School of Nursing
New Haven, CT
Lance F. Ortega, MBA, BSN, RN, OCN
Executive Director, Clinical Operations
Texas Oncology
Dallas-Fort Worth, TX
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Pharmacotherapy credit for Advanced Practice Registered Nurses to be determined.
DISCLOSURE OF CONFLICTS OF INTEREST
Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
All relevant financial relationships have been mitigated.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Faculty
Marianne J. Davies, DNP, ACNP, AOCNP, FAAN, has no relevant financial relationships to disclose.
Lance F. Ortega, MBA, BSN, RN, OCN, has no relevant financial relationships to disclose.
Planners, Managers, and Reviewer
The Talem Health planners, managers, and reviewer have nothing to disclose.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
CONTACT US
For questions about this program, please contact RME Collaborative (a division of Talem Health) at 800-913-9370 or cme@cmeruralhealth.com.
MEDIA
Internet activity
COMPUTER SYSTEM REQUIREMENTS
FEE INFORMATION
There is no fee for this educational activity.
COPYRIGHT
©RME Collaborative, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.